Leukotriene receptor antagonists (LTRA) are a new class of drugs for asthma
treatment, available in tablet form. Their unique mechanism of action resu
lts in a combination of both bronchodilator and anti-inflammatory effects.
While their optimal place in asthma management is still under review, LTRA
represent an important advance in asthma pharmacotherapy.